Abstract
A cohort of 439 haematopoietic SCT recipients was analysed to determine the incidence of Gram-positive coccal bacteraemia and thromboembolic events associated with the use of central venous catheters (CVCs) and to determine risk factors for these complications. The incidences of persistent coagulase-negative staphylococcal (CoNS) bacteraemia, symptomatic thrombosis and thrombophlebitis were 25%, 9.6% and 6.6%, respectively. Duration of neutropenia (in days, odds ratio (OR) 1.02; P=0.04) and left-sided placement of the CVCs (OR 1.73; P=0.03) were independent risk factors for the occurrence of persistent CoNS bacteraemia, whereas the use of less mucotoxic conditioning regimens was associated with a lower risk (high-dose melphalan (HDM)/BEAM vs other regimens, OR 0.24; P<0.001). Use of TBI, persistent CoNS bacteraemia and tip colonisation were all significantly associated with an increased risk of symptomatic thrombosis (OR 6.03, 3.36 and 2.80, respectively; P⩽0.02). The risk factors found in this cohort of SCT recipients differed from those found in the general cancer population, showing an important role for persisting bacteraemia in the pathogenesis of CVC-associated thrombosis. Therefore, we constructed a new algorithm in order to improve catheter management and prevent these CVC-related complications.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Boersma RS, Jie KS, Verbon A, van Pampus EC, Schouten HC . Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies. Ann Oncol 2008; 19: 433–442.
Safdar N, Maki DG . The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med 2004; 30: 62–67.
Slobbe L, Doorduijn JK, Lugtenburg PJ, El Barzouhi A, Boersma E, van Leeuwen WB et al. Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial. PLoS One 2010; 5: e10840.
Geenen IL, Post MJ, Molin DG, Schurink GW, Maessen JG, van Oerle R et al. Coagulation on endothelial cells: the underexposed part of Virchow’s Triad. Thromb Haemost 2012; 108: 863–871.
van Rooden CJ, Schippers EF, Barge RM, Rosendaal FR, Guiot HF, van der Meer FJ et al. Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: a prospective study. J Clin Oncol 2005; 23: 2655–2660.
Picardi M, Pagliuca S, Chiurazzi F, Iula D, Catania M, Rossano F et al. Early ultrasonographic finding of septic thrombophlebitis is the main indicator of central venous catheter removal to reduce infection-related mortality in neutropenic patients with bloodstream infection. Ann Oncol 2012; 23: 2122–2128.
Chrissoheris MP, Libertin C, Ali RG, Ghantous A, Bekui A, Donohue T . Endocarditis complicating central venous catheter bloodstream infections: a unique form of health care associated endocarditis. Clin Cardiol 2009; 32: E48–E54.
Costa SF, Barone AA, Miceli MH, van der Heijden IM, Soares RE, Levin AS et al. Colonization and molecular epidemiology of coagulase-negative Staphylococcal bacteremia in cancer patients: a pilot study. Am J Infect Control 2006; 34: 36–40.
Herbers AH, Blijlevens NM, Donnelly JP, de Witte TJ . Bacteraemia coincides with low citrulline concentrations after high-dose melphalan in autologous HSCT recipients. Bone Marrow Transplant 2008; 42: 345–349.
van der Velden WJ, Herbers AH, Feuth T, Schaap NP, Donnelly JP, Blijlevens NM . Intestinal damage determines the inflammatory response and early complications in patients receiving conditioning for a stem cell transplantation. PLoS One 2010; 5: e15156.
O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2011; 39 (4 Suppl 1): S1–34.
Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S . Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann of Intern Med 2002; 136: 792–801.
MacGregor RR, Beaty HN . Evaluation of positive blood cultures. Guidelines for early differentiation of contaminated from valid positive cultures. Arch Intern Med 1972; 130: 84–87.
Miceli MH, Jones Jackson LB, Walker RC, Talamo G, Barlogie B, Anaissie EJ . Diagnosis of infection of implantable central venous catheters by [18F]fluorodeoxyglucose positron emission tomography. Nucl Med Commun 2004; 25: 813–818.
Vos FJ, Donnelly JP, Oyen WJ, Kullberg BJ, Bleeker-Rovers CP, Blijlevens NM . 18F-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation. Eur J Nucl Med Mol Imaging 2012; 39: 120–128.
Deshpande KS, Hatem C, Ulrich HL, Currie BP, Aldrich TK, Bryan-Brown CW et al. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit Care Med 2005; 33: 13–20 discussion 234–5.
Fijnheer R, Paijmans B, Verdonck LF, Nieuwenhuis HK, Roest M, Dekker AW . Factor V Leiden in central venous catheter-associated thrombosis. Br J Haematol 2002; 118: 267–270.
van Rooden CJ, Rosendaal FR, Barge RM, van Oostayen JA, van der Meer FJ, Meinders AE et al. Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler-ultrasound. Br J Haematol 2003; 123: 507–512.
Tesselaar ME, Ouwerkerk J, Nooy MA, Rosendaal FR, Osanto S . Risk factors for catheter-related thrombosis in cancer patients. Eur J Cancer 2004; 40: 2253–2259.
Stoffel N, Rysler C, Buser A, Gratwohl A, Tsakiris DA, Stern M . Leukocyte count and risk of thrombosis in patients undergoing haematopoietic stem cell transplantation or intensive chemotherapy. Thromb Haemost 2010; 103: 1228–1232.
Gerber DE, Segal JB, Levy MY, Kane J, Jones RJ, Streiff MB . The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention. Blood 2008; 112: 504–510.
Pihusch R, Danzl G, Scholz M, Harich D, Pihusch M, Lohse P et al. Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma. Cancer 2002; 94: 3120–3126.
Gonsalves A, Carrier M, Wells PS, McDiarmid SA, Huebsch LB, Allan DS . Incidence of symptomatic venous thromboembolism following hematopoietic stem cell transplantation. J thromb haemost 2008; 6: 1468–1473.
Paris F, Fuks Z, Kang A, Capodieci P, Juan G, Ehleiter D et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001; 293: 293–297.
Takatsuka H, Wakae T, Mori A, Okada M, Okamoto T, Kakishita E . Effects of total body irradiation on the vascular endothelium. Clin Transplant 2002; 16: 374–377.
Saber W, Moua T, Williams EC, Verso M, Agnelli G, Couban S et al. Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb Haemost 2011; 9: 312–319.
Kamphuisen PW, Lee AY . Catheter-related thrombosis: lifeline or a pain in the neck? Hematology Am Soc Hematol Educ Program 2012; 2012: 638–644.
Penack O, Rempf P, Eisenblatter M, Stroux A, Wagner J, Thiel E et al. Bloodstream infections in neutropenic patients: early detection of pathogens and directed antimicrobial therapy due to surveillance blood cultures. Ann Oncol 2007; 18: 1870–1874.
Frere P, Hermanne JP, Debouge MH, de Mol P, Fillet G, Beguin Y . Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures. Bone Marrow Transplant 2004; 33: 745–749.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Author contributions
AR, MvV, JPD and WvdV conceived and designed the study; AR, MvV and JPD acquired the data; AR and WvdV analysed the data; AR, MvV, JPD and WvdV interpreted the results; and AR, MvV, JPD and WvdV drafted the manuscript. All authors revised the manuscript and approved the final version.
Rights and permissions
About this article
Cite this article
Richters, A., van Vliet, M., Peer, P. et al. Incidence of and risk factors for persistent gram-positive bacteraemia and catheter-related thrombosis in haematopoietic stem cell transplantation. Bone Marrow Transplant 49, 264–269 (2014). https://doi.org/10.1038/bmt.2013.172
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2013.172
Keywords
This article is cited by
-
Grading bloodstream infection risk using citrulline as a biomarker of intestinal mucositis in patients receiving intensive therapy
Bone Marrow Transplantation (2022)
-
Central venous catheter–related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
Annals of Hematology (2021)
-
Venous thromboembolism following hematopoietic stem cell transplantation—a systematic review and meta-analysis
Annals of Hematology (2016)
-
Central venous catheter-related thrombosis in senile male patients: New risk factors and predictors
Journal of Huazhong University of Science and Technology [Medical Sciences] (2015)
-
A systematic review of patient-related risk factors for catheter-related thrombosis
Journal of Thrombosis and Thrombolysis (2015)